ATE233763T1 - Pharmazeutische wirksame trizyklische amine - Google Patents

Pharmazeutische wirksame trizyklische amine

Info

Publication number
ATE233763T1
ATE233763T1 AT97955063T AT97955063T ATE233763T1 AT E233763 T1 ATE233763 T1 AT E233763T1 AT 97955063 T AT97955063 T AT 97955063T AT 97955063 T AT97955063 T AT 97955063T AT E233763 T1 ATE233763 T1 AT E233763T1
Authority
AT
Austria
Prior art keywords
pharmaceutically active
tricyclic amine
active tricyclic
amine
pyrimido
Prior art date
Application number
AT97955063T
Other languages
English (en)
Inventor
Gordon L Bundy
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE233763T1 publication Critical patent/ATE233763T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Cosmetics (AREA)
AT97955063T 1997-01-08 1997-12-19 Pharmazeutische wirksame trizyklische amine ATE233763T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3522397P 1997-01-08 1997-01-08
US4374997P 1997-04-09 1997-04-09
PCT/US1997/024300 WO1998042708A2 (en) 1997-01-08 1997-12-19 Pharmaceutically active tricyclic amines

Publications (1)

Publication Number Publication Date
ATE233763T1 true ATE233763T1 (de) 2003-03-15

Family

ID=26711898

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97955063T ATE233763T1 (de) 1997-01-08 1997-12-19 Pharmazeutische wirksame trizyklische amine

Country Status (22)

Country Link
US (1) US5932728A (de)
EP (1) EP0964865B1 (de)
JP (1) JP2002511061A (de)
KR (1) KR20000069940A (de)
CN (1) CN1128798C (de)
AT (1) ATE233763T1 (de)
AU (1) AU723709B2 (de)
CA (1) CA2275389A1 (de)
CZ (1) CZ288076B6 (de)
DE (1) DE69719563T2 (de)
DK (1) DK0964865T3 (de)
ES (1) ES2193424T3 (de)
FI (1) FI991568A7 (de)
HU (1) HUP0003692A3 (de)
NO (1) NO312463B1 (de)
NZ (1) NZ336659A (de)
PL (1) PL334451A1 (de)
PT (1) PT964865E (de)
RU (1) RU2200737C2 (de)
SI (1) SI0964865T1 (de)
SK (1) SK283378B6 (de)
WO (1) WO1998042708A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors
PT1255544E (pt) * 2000-01-31 2007-06-15 Genaera Corp Inibidores da síntese da mucina.
US7345051B2 (en) 2000-01-31 2008-03-18 Genaera Corporation Mucin synthesis inhibitors
CA2464934A1 (en) * 2001-10-31 2003-05-08 Bayer Healthcare Ag Pyrimido [4,5-b] indole derivatives
AU2003300522A1 (en) * 2002-12-27 2004-07-22 Bayer Healthcare Ag 4-phenyl-pyrimido (4,5-b) indole derivatives
JP5838157B2 (ja) * 2009-07-22 2015-12-24 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ Ｈｄａｃ阻害剤およびそれを用いる治療法
PH12013501800A1 (en) 2011-03-15 2013-10-14 L Livermore Nat Security Llc Tricyclic gyrase inhibitors
SI2807165T1 (sl) 2012-01-27 2019-08-30 Universite De Montreal Pirimido(4,5-B)indol derivati in njihova uporaba pri ekspanziji hematopoetskih matičnih celic
WO2016191879A1 (en) 2015-06-05 2016-12-08 Héma-Québec Methods for culturing and/or differentiating hematopoietic stem cells into progenitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5502187A (en) * 1992-04-03 1996-03-26 The Upjohn Company Pharmaceutically active bicyclic-heterocyclic amines
PT633886E (pt) * 1992-04-03 2001-03-30 Upjohn Co Aminas biciclicas-heterociclicas farmaceuticamente activas
NZ304519A (en) * 1995-03-02 2000-01-28 Upjohn Co Pydrimido[4,5-b]indoles

Also Published As

Publication number Publication date
NO312463B1 (no) 2002-05-13
US5932728A (en) 1999-08-03
PL334451A1 (en) 2000-02-28
WO1998042708A2 (en) 1998-10-01
HK1023344A1 (en) 2000-09-08
NO993359D0 (no) 1999-07-07
HUP0003692A3 (en) 2002-10-28
FI991568L (fi) 1999-07-08
CN1128798C (zh) 2003-11-26
NO993359L (no) 1999-09-07
DE69719563D1 (de) 2003-04-10
HUP0003692A2 (hu) 2001-04-28
EP0964865B1 (de) 2003-03-05
CN1239961A (zh) 1999-12-29
PT964865E (pt) 2003-06-30
SK90199A3 (en) 2000-05-16
EP0964865A2 (de) 1999-12-22
SI0964865T1 (en) 2003-08-31
SK283378B6 (sk) 2003-06-03
CA2275389A1 (en) 1998-10-01
CZ238899A3 (cs) 1999-10-13
NZ336659A (en) 2001-01-26
CZ288076B6 (cs) 2001-04-11
AU8655498A (en) 1998-10-20
KR20000069940A (ko) 2000-11-25
DE69719563T2 (de) 2003-11-27
FI991568A7 (fi) 1999-07-08
JP2002511061A (ja) 2002-04-09
AU723709B2 (en) 2000-09-07
ES2193424T3 (es) 2003-11-01
WO1998042708A3 (en) 1998-12-17
RU2200737C2 (ru) 2003-03-20
DK0964865T3 (da) 2003-05-05

Similar Documents

Publication Publication Date Title
CA2160447A1 (en) Amino(thio)ether derivatives
PL319833A1 (en) Compounds and composition for carrying active media
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
HUT50767A (en) Process for producing new 1,3,4,5-tetrahydro-benz/c,d/indole derivatives and pharmaceutical compositions comprising such compounds
AU1945795A (en) Thieno{ 2,3-b}indoles, their preparation and use
BR9707659A (pt) Pirrol(2,3-C) carbarzol-6-onas que potencializam atividade atividade de interferon gama
YU31492A (sh) Heterociklični-4-amino-1,3,4,5-tetrahidrobenz[cd]indoli
IL106737A0 (en) Indole and indoline derivatives, process for their preparation and use as medicament
CZ238899A3 (cs) Farmaceuticky aktivní tricyklické aminy
EE03830B1 (et) 1H-pürido[3,4-b]indool-4-karboksamiidi derivaadid, nende valmistamismeetodid ja kasutamine raviks
GEP20105095B (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
BG101379A (en) New pypimido [1,2-a] indoles
HUP0102936A3 (en) New process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3-acetamide and salts thereof
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
CA2298820A1 (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives
FI894506L (fi) Menetelmä valmistaa terapeuttisesti aktiivisia pyrido/1,2-a/indolijohdannaisia
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
IE840119L (en) Pyrido indoles
ES2007265A6 (es) Un metodo para preparar conjugados de indol-portador biologicamente activos.
CA2303132A1 (en) Intranasal formulations containing scopolamine and method of treating motion sickness
EE200100700A (et) Asendatud [1,4]diasepino[6,7,1-hi]indool-4-oonidevalmistamismeetod
DE60036955D1 (de) HERSTELLUNG VON i3,5,7ö-1H-IMIDAZOi1,5-AöIMIDAZOL-2(3H)-ON-VERBINDUNGEN
MXPA02001308A (es) Derivados de pirido (1, 2-a)bencimidazol sustituidos en el anillo c-6 utiles en el tratamiento de trastornos del sistema nervioso central.
CA2241852A1 (en) Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0964865

Country of ref document: EP

REN Ceased due to non-payment of the annual fee